These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15896777)

  • 1. The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells.
    Auger-Messier M; Turgeon ES; Leduc R; Escher E; Guillemette G
    Exp Cell Res; 2005 Aug; 308(1):188-95. PubMed ID: 15896777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
    Auger-Messier M; Arguin G; Chaloux B; Leduc R; Escher E; Guillemette G
    Mol Endocrinol; 2004 Dec; 18(12):2967-80. PubMed ID: 15331757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.
    Auger-Messier M; Clement M; Lanctot PM; Leclerc PC; Leduc R; Escher E; Guillemette G
    Endocrinology; 2003 Dec; 144(12):5277-84. PubMed ID: 12960024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational induction is the key process for activation of the AT1 receptor.
    Ellis J; Warburton P; Donnelly D; Balmforth AJ
    Biochem Pharmacol; 2006 Feb; 71(4):464-71. PubMed ID: 16343447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-biphenyl-tetrazole angiotensin AT
    Takezako T; Unal H; Karnik SS; Node K
    Br J Pharmacol; 2018 Jun; 175(12):2454-2469. PubMed ID: 29570771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity.
    Feng YH; Zhou L; Qiu R; Zeng R
    Mol Pharmacol; 2005 Aug; 68(2):347-55. PubMed ID: 15901848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 receptors and the actin cytoskeleton during angiotensin II treatment.
    Bertels IM; Gontijo JA; Figueiredo JF
    J Nephrol; 2007; 20(1):29-35. PubMed ID: 17347970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function polymorphic variants of the human angiotensin II type 1 receptor.
    Hansen JL; Haunsø S; Brann MR; Sheikh SP; Weiner DM
    Mol Pharmacol; 2004 Mar; 65(3):770-7. PubMed ID: 14978256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.
    Zhai P; Yamamoto M; Galeotti J; Liu J; Masurekar M; Thaisz J; Irie K; Holle E; Yu X; Kupershmidt S; Roden DM; Wagner T; Yatani A; Vatner DE; Vatner SF; Sadoshima J
    J Clin Invest; 2005 Nov; 115(11):3045-56. PubMed ID: 16276415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z; Jin L; Palmer T; Webb RC
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of homologous internalization of constitutively active N111G mutant of AT(1) receptor.
    Bhuiyan MA; Nagatomo T
    Methods Enzymol; 2010; 484():165-77. PubMed ID: 21036232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
    Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
    Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
    Hennenberg M; Trebicka J; Biecker E; Schepke M; Sauerbruch T; Heller J
    Hepatology; 2007 Feb; 45(2):495-506. PubMed ID: 17256744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor.
    Lee C; Hwang SA; Jang SH; Chung HS; Bhat MB; Karnik SS
    FEBS Lett; 2007 May; 581(13):2517-22. PubMed ID: 17498700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively active mutant N111G of angiotensin II type 1 (AT(1)) receptor induces homologous internalization through mediation of AT(1)-receptor antagonist.
    Bhuiyan MA; Hossain M; Miura S; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2009 Nov; 111(3):227-34. PubMed ID: 19881223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.
    Nikiforovich GV; Mihalik B; Catt KJ; Marshall GR
    J Pept Res; 2005 Nov; 66(5):236-48. PubMed ID: 16218991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway.
    Song J; Kost CK; Martin DS
    Cardiovasc Res; 2006 Dec; 72(3):456-63. PubMed ID: 17049502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists.
    Assunção-Miranda I; Guilherme AL; Reis-Silva C; Costa-Sarmento G; Oliveira MM; Vieyra A
    Regul Pept; 2005 Apr; 127(1-3):151-7. PubMed ID: 15680481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteration of signal transduction-associated gene expression in rat cardiac fibroblasts induced by blocking angiotensin II receptors].
    Jiang XY; Gao GD; Wang XF; Lin YX; Wang YW; Yang YB
    Sheng Li Xue Bao; 2006 Dec; 58(6):556-66. PubMed ID: 17173190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.